Johnson & Johnson’s CVRx CVRX Stock Holding History

Johnson & Johnson’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.7M	Hold	4,024,861	–	–	2.59%	7
2026 Q1	$38.1M	Hold	4,024,861	–	–	5.84%	5
2025 Q4	$28.6M	Sell	4,024,861 -78,569	-2%	-$717K	5.15%	5
2025 Q3	$33.1M	Hold	4,103,430	–	–	6.57%	5
2025 Q2	$23.9M	Hold	4,103,430	–	–	7.15%	6
2025 Q1	$50.2M	Hold	4,103,430	–	–	14.68%	2
2024 Q4	$52M	Hold	4,103,430	–	–	13.46%	2
2024 Q3	$36.2M	Hold	4,103,430	–	–	8.46%	5
2024 Q2	$49.2M	Hold	4,103,430	–	–	12.28%	3
2024 Q1	$74.7M	Buy	4,103,430 +607,855	+17%	+$14.4M	1.69%	3
2023 Q4	$110M	Hold	3,495,575	–	–	2.51%	2
2023 Q3	$53M	Hold	3,495,575	–	–	19.53%	2
2023 Q2	$54M	Hold	3,495,575	–	–	16.76%	3
2023 Q1	$32.6M	Hold	3,495,575	–	–	10.6%	4
2022 Q4	$64.1M	Hold	3,495,575	–	–	18.66%	2
2022 Q3	$32.6M	Hold	3,495,575	–	–	9.6%	4
2022 Q2	$21M	Hold	3,495,575	–	–	5.37%	6
2022 Q1	$20.9M	Hold	3,495,575	–	–	3.96%	9
2021 Q4	$42.8M	Hold	3,495,575	–	–	4.87%	7
2021 Q3	$57.8M	Buy	+3,495,575	New	+$67.1M	5.07%	6

Other funds holding CVRX

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Johnson & Johnson's CVRX Position: Q2 2026 in Review

Johnson & Johnson held its CVRx (CVRX) position steady in Q2 2026 at 4,024,861 shares worth $20.7M. The position accounts for 2.59% of the portfolio, ranked #7.

Johnson & Johnson first reported a position in CVRX in Q3 2021 and has held it in 20 quarters since. The position peaked at $110M in Q4 2023. 88 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

Johnson & Johnson held 4,024,861 shares of CVRx worth $20.7M as of Q2 2026.
Johnson & Johnson left its CVRx share count unchanged in Q2 2026.
CVRx made up 2.59% of Johnson & Johnson's portfolio in Q2 2026, its #7 holding.
Johnson & Johnson first reported a position in CVRx in Q3 2021 and has held it in 20 quarters since.
Johnson & Johnson's CVRx position peaked at $110M in Q4 2023.
88 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on Johnson & Johnson's 13F filing for Q2 2026, filed 6 Aug 2026.